Additionally, few studies have examined severe hyperglycemia (defined as HbA1c level >10%), which insulin therapy specifically aims to address.4 Understanding these trends can inform health policy and public health initiatives to improve glycemic control in patients receiving insulin. The gene discussed is INS; the disease is Hyperglycemia.